Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 GBX | -4.17% |
|
-14.81% | -75.53% |
06-14 | IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study | MT |
06-14 | IQ-AI team begins defining phase 2 protocol for oral gallium maltolate | AN |
Business Summary
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Software
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +13.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 12/02/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 12/02/15 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 19/01/17 |
Director/Board Member | - | 17/12/19 | |
Brett Skelly
BRD | Director/Board Member | - | 01/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 221,709,789 | 136,845,642 ( 61.72 %) | 0 | 61.72 % |
Company contact information
![address IQ-AI Limited(IQAI)](https://cdn.zonebourse.com/static/address/39085176.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-75.53% | 3.38M | |
-17.74% | 8.18B | |
+68.25% | 4.32B | |
+5.67% | 2.74B | |
-2.98% | 2.62B | |
-51.24% | 1.95B | |
-19.04% | 1.67B | |
-22.78% | 1.41B | |
+16.69% | 1.2B | |
-44.81% | 1.12B |
- Stock Market
- Equities
- IQAI Stock
- Company IQ-AI Limited